Drug to Treat Low Sexual Desire in Women Has Mild Effect by Angela Mohan on March 8, 2021 at 6:11 PM
The analysis, published in the peer-reviewed
Journal of Sex Research, also highlights issues with the validity of HSDD as a diagnosis. The condition was removed from the American Diagnostic and Statistical Manual of Mental Disorders (DSM-5) in 2013.
Professor Glen Spielmans, of Metropolitan State University, USA, examined data from bremelanotide s FDA New Drug Application, the clinicaltrials.gov protocol entries for the two 24-week Phase III trials, and the journal article (Kingsberg et al., published in
Obstetrics and Gynecology) that reported both trials.
He also conducted a meta-analysis of efficacy and dropout data appearing in the FDA application and compared these outcomes to those reported in the journal paper.
FDA-approved drug has limited treatment efficacy for hypoactive sexual desire disorder
news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.
Drug to treat hypoactive sexual desire disorder in women of very limited use
eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.